MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.240
-0.030 (-2.36%)
Jun 26, 2026, 4:00 PM EDT - Market closed
MaxCyte Employees
MaxCyte had 91 employees as of December 31, 2025. The number of employees decreased by 23 or -20.18% compared to the previous year.
Employees
91
Change (1Y)
-23
Growth (1Y)
-20.18%
Revenue / Employee
$354,802
Profits / Employee
-$429,879
Market Cap
132.83M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Inogen | 753 |
| Neuronetics | 658 |
| InfuSystem Holdings | 473 |
| Quanterix | 450 |
| AVITA Medical | 226 |
| CVRx, Inc. | 223 |
| Apyx Medical | 205 |
| Quantum-Si incorporated | 145 |
MXCT News
- 5 days ago - VectorBuilder Partners With MaxCyte® to Advance Clinical-Grade Cell Engineering - Business Wire
- 6 weeks ago - MaxCyte reports Q1 EPS (4c), consensus (9c) - TheFly
- 6 weeks ago - MaxCyte backs FY26 revenue view $30M-$32M, consensus $30.83M - TheFly
- 6 weeks ago - MaxCyte Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - MaxCyte Earnings release: Q1 2026 - Filings
- 6 weeks ago - MaxCyte Quarterly report: Q1 2026 - Filings
- 6 weeks ago - MaxCyte Reports First Quarter 2026 Financial Results and Reiterates Full Year 2026 Guidance - GlobeNewsWire
- 2 months ago - MaxCyte to Report First Quarter 2026 Financial Results on May 12, 2026 - GlobeNewsWire